Evidence map›Paper›PMID 35954945›Full record

ArticleInternational journal of environmental research and public health2022

COVID-19 Pandemic and Consumption of Dietary Supplements among Adult Residents of Lithuania.

Rokas Arlauskas, Donatas Austys, Rimantas Stukas

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rokas ArlauskasDepartment of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio 21/27, LT-03101 Vilnius, Lithuania.
Donatas AustysDepartment of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio 21/27, LT-03101 Vilnius, Lithuania.ORCID 0000-0002-2374-5481
Rimantas StukasDepartment of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio 21/27, LT-03101 Vilnius, Lithuania.
Vilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the light of the changing pattern of the consumption of dietary supplements among adults in other countries during the COVID-19 pandemic, we aim to assess the prevalence of the consumption of dietary supplements with respect to the purpose of consumption and sociodemographic factors among adults in Lithuania. This study included two samples of adults from Lithuania: 870 in 2019 and 1600 in 2021. Anonymous original questionnaires were used to collect the data about the consumption of dietary supplements before and during the pandemic. The consumption of dietary supplements was prevalent among 67.2% and 78.1% of the samples, respectively. Although the majority (73.7%) of the respondents indicated that the pandemic had no effect on their use of dietary supplements, every fourth respondent’s (24.6%) consumption increased. In 2021, the consumption was more prevalent among females, respondents with university education, urban citizens, employed respondents, respondents without children, with higher income, and those who knew a person with COVID-19 (p < 0.05). During the pandemic, the strengthening of the immune system and the body were the leading reasons for consumption (49.0% and 43.5%, respectively). The consumption of dietary supplements appropriate for these purposes increased among 63.3% and 66.9% of respondents, respectively. To conclude, the consumption of dietary supplements among adults in Lithuania increased during the COVID-19 pandemic.

Indexed as

COVID-19AdultChildCross-Sectional StudiesDietary SupplementsFemaleHumansLithuaniaPandemicsSurveys and QuestionnairesadultsCOVID-19dietary supplementsLithuania

Identifiers

PMID35954945
PMCPMC9368138
OpenAlexW4289997254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.